Table 1.
Epidemiologic and transplant data
| All patients (n = 48) | Group 1 (n = 15) | Group 2 (n = 14) | Group 3 (n = 15) | Group 4 (n = 4) | ||
|---|---|---|---|---|---|---|
| Age (years) | 51.14 ± 8.73 | 51.86 ± 5.47 | 46.57 ± 11.6 | 57.73 + 4.18 | 39.75 ± 17.25 | |
| Sex | Male | 30 (62.5%) | 10 (66.6%) | 9 (64.2%) | 9 (60%) | 2 (50%) |
| Female | 18 (37.5%) | 5 (33.3%) | 5 (35.7%) | 6 (26%) | 2 (50%) | |
| Etiology of liver disease | HVB | 26 (54.1%) | 6 (26%) | 5 (35.7%) | 12 (80%) | 1 (25%) |
| HVC | 11 (22.9%) | 5 (33.3%) | 4 (28.5%) | 2 (13.3%) | 0 (0%) | |
| HVD | 14 (29%) | 4 (26%) | 4 (28.5%) | 6 (26%) | 0 (0%) | |
| Alcoholic | 9 (18.75%) | 5 (33.3%) | 2 (14.2%) | 1 (6.6%) | 1 (25%) | |
| HCC | 7 (14.5%) | 1 (6.6%) | 0 (0%) | 6 (26%) | 0 (0%) | |
| Others | 7 (14.5%) | 1 (6.6%) | 3 (21.4%) | 1 (6.6%) | 2 (50%) | |
| Arterial lactate (mmol/L) | 2.77 ± 1.22 | 1.2 ± 0.24 | 2.39 ± 0.36 | 3.68 ± 0.41 | 6.6 ± 1.15 | |
| INR | 1.75 ± 0.39 | 1.66 ± 0.26 | 1.52 ± 0.18 | 1.7 ± 0.25 | 3.23 ± 1.36 | |
| Fibrinogen (mg/dL) | 165 ± 45 | 174 ± 50 | 177 ± 42 | 152 ± 44 | 144 ± 51 | |
| Duration of surgery (min) | 407 ± 77 | 385 ± 75 | 405 ± 88 | 416 ± 62 | 462 ± 67 | |
| Intraoperative bleeding (mL) | 4550 ± 3200 | 3260 ± 1800 | 3380 ± 1790 | 5106 ± 3600 | 11370 ± 6370 | |
| Length of stay in the ICU (days) | 8.85 ± 3.7 | 6.6 ± 1.65 | 8.15 ± 3.05 | 8.53 ± 2.37 | 21 ± 10.5 | |
| Mortality (at 30 days) | 6 (12.5%) | 0 (0%) | 0 (0%) | 2 (13.3%) | 4 (100%) |
HVB – Hepatitis virus B; HVC – Hepatitis virus C; HVD – Hepatitis virus D; INR – International normalized ratio; HCC – Hepatocellular carcinoma; ICU – Intensive care unit